Pharmaceuticals
Physician Payments Sunshine Act data collection takes effect January 1, 2012. Are you prepared?
While no one is surprised that HHS missed its October 1, 2011 deadline for publishing reporting guidelines to the healthcare industry for Physician Payments Sunshine Act reporting, the bottom line is a lack of performance on CMS’s part to provide direction to the industry should not be (and likely will not be) considered an excuse for a lack of preparedness for data collection by covered reporting entities (U.S. drug, medical device, biological or medical supply manufacturers).
Healthy Data Webinar – Check in on the checkup for the Sunshine Act
After a well-attended session at CBI's 5th Annual Tracking State Laws and Aggregate Spend , Health Market Science and CBI decided to create a follow-up webinar that echoes some points offered in my August presentation, while offering more detail on the cost of poor quality data.
Q: Is the industry ready to comply with aggregate spend regs? A: Surprisingly, maybe not.
As a speaker at the CBI Aggregate Spend Conference last week, (with a timely agenda and a great turnout) I was looking forward to gauging Life Science organizations’ response to what will soon be the final regs of the Sunshine Act. I was quickly enlightened. With the first session, I could tell participants were still learning the options for overcoming the challenges of transparency. In fact, some are still in the planning stage!
The Pharma C-Suite is under increased scrutiny from the feds. Why should it have to get personal?
The recent Associated Press article, In shift, feds target top execs for health fraud, may rattle some chains in healthcare’s C-suite. In the article, the author suggests that “Federal enforcers are targeting individual executives in health care fraud cases that used to be aimed at impersonal corporations.” The notion of holding executives accountable has grown since the economic recession.
A perspective on the hidden value of the Physician Payments Sunshine Act
When the moon is in the seventh house (Pelosi’s House, that is)
And Jupiter aligns with Mars (Congress finally passes a healthcare reform bill)
Then peace will guide the planets (peace = improved and expanded coverage dictated to the insurers)
And love will steer the stars (love for the uninsured)
Identify market opportunities by focusing on high-volume targets
PxDx helps healthcare companies optimize market opportunities and improve sales execution including:
- Targeting of hospital based and specialty based sales forces
- Call planning
- Segmentation
- Territory Alignment
- Sales force sizing and structure
- Compensation design
- Patient flow analysis
- Managed markets sales planning and opportunity sizing
- Non personal promotion
An enterprise view of a healthcare practitioner requires effective Master Data Management (MDM).
This means assimilating and cleansing data from a variety of sources to create one master record.
With mounting regulatory demands, the need for an efficient path to a trusted master record is essential to mitigate risk. Your data needs to be thorough, up-to-date, and accurate.
Meet Aggregate Spend Challenges Head on with CompleteSpend™
Today, legislation requires Life Sciences organizations to report their spending including promotion, education, consulting, and grant per practitioner and/or facility.
Maximize Aggregate Spend Investment with High Quality and Actionable Data
Read about our proven track record in the March IDC Health Aggregate Spend Report.
Customer Data Management in the Cloud.
Health Market Science’s CompleteView® is a fully managed and hosted solution that delivers actionable data based on millions of healthcare practitioners, their related organizations and affiliations. You get limitless options to define business rules about your customer and rank source priorities.
We do the work, you have the control.
The transition to cloud based customer management is worth it because entire organization benefits:
